The utility of MRI for the screening and staging of breast cancer
- 14 January 2008
- journal article
- research article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 62 (3), 450-453
- https://doi.org/10.1111/j.1742-1241.2007.01677.x
Abstract
Contrast-enhanced magnetic resonance imaging (MRI) of the breast has been recently introduced as a potential clinical tool for the detection, diagnosis, staging and management of breast cancer. In this article, we consider the established and evolving roles of MRI with particular reference to screening in high risk women and staging of the primary tumour. Controversies are discussed in the context of the tumour biology and natural history of breast cancer.Articles were identified by searches of PubMed and MEDLINE up to October 2007.Contrast-enhanced MRI is an effective tool for screening women at high risk of breast cancer. However, randomized trials have yet to demonstrate a reduction in mortality. MRI can also facilitate local staging, in particular, the evaluation of ipsilateral multicentric or multifocal lesions and synchronous contralateral disease which may be 'missed' by conventional imaging. However, efficacy with respect to clinically relevant and patient oriented end-points has yet to be addressed in the context of clinical trials.In women at high risk of breast cancer, screening MRI should be used in conjunction with published guidelines. In women with newly diagnosed breast cancer, the utility of MRI is less clearly defined and should be restricted to selected cases within the multidisciplinary setting.Keywords
This publication has 30 references indexed in Scilit:
- Screening for breast cancer with mammographyCochrane Database of Systematic Reviews, 2013
- MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast CancerNew England Journal of Medicine, 2007
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) trialJournal of Surgical Oncology, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- MR Imaging Findings in the Contralateral Breast of Women with Recently Diagnosed Breast CancerAmerican Journal of Roentgenology, 2003
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Magnetic resonance imaging for primary breast cancer management: current role and new applications.Endocrine-Related Cancer, 2002
- Multicentricity and recurrence of breast cancerThe Lancet, 1997
- Multicentricity of breast cancer: whole-organ analysis and clinical implicationsBritish Journal of Cancer, 1996